Literature DB >> 12853012

Sleepiness and residual sleepiness in adults with obstructive sleep apnea.

Jed Black1.   

Abstract

Sleepiness is a common, but not necessary symptom of the obstructive sleep apnea syndrome (OSA) and is a frequent chief complaint of patients with OSA who seek medical attention. While sleepiness may seem simple in nature, the underlying mechanisms producing daytime sleepiness in OSA are complex and poorly characterized. Moreover, the meaningful assessment of pathological sleepiness is frequently far from straightforward. Effective treatment of OSA is generally expected to resolve or ameliorate daytime sleepiness. An unknown percentage of treated OSA patients, however, remain sleepy during waking hours. The assessment and treatment of residual sleepiness in treated OSA can range from simple to difficult, depending on the nature and causes of the continued sleepiness. Recently, however, data from clinical trials have been generated which provide direction in the evaluation and management of the OSA patient suffering residual daytime sleepiness.

Entities:  

Mesh:

Year:  2003        PMID: 12853012     DOI: 10.1016/s1569-9048(03)00083-1

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  12 in total

1.  Seeking useful biomarkers for the quality and effectiveness of sleep.

Authors:  Robert Joseph Thomas
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

Review 2.  Spousal involvement and CPAP adherence: a dyadic perspective.

Authors:  Lichuan Ye; Atul Malhotra; Karen Kayser; Danny G Willis; June A Horowitz; Mark S Aloia; Terri E Weaver
Journal:  Sleep Med Rev       Date:  2014-05-09       Impact factor: 11.609

3.  Ethnic disparities in CPAP adherence in New Zealand: effects of socioeconomic status, health literacy and self-efficacy.

Authors:  Jessie P Bakker; Karyn M O'Keeffe; Alister M Neill; Angela J Campbell
Journal:  Sleep       Date:  2011-11-01       Impact factor: 5.849

4.  Gender differences in obstructive sleep apnea and treatment response to continuous positive airway pressure.

Authors:  Lichuan Ye; Grace W Pien; Sarah J Ratcliffe; Terri E Weaver
Journal:  J Clin Sleep Med       Date:  2009-12-15       Impact factor: 4.062

5.  Modafinil improves functional outcomes in patients with residual excessive sleepiness associated with CPAP treatment.

Authors:  Terri E Weaver; Eileen R Chasens; Sanjay Arora
Journal:  J Clin Sleep Med       Date:  2009-12-15       Impact factor: 4.062

6.  Treatment of sleep disorders after traumatic brain injury.

Authors:  Richard J Castriotta; Strahil Atanasov; Mark C Wilde; Brent E Masel; Jenny M Lai; Samuel T Kuna
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

7.  Patient education combined in a music and habit-forming intervention for adherence to continuous positive airway (CPAP) prescribed for sleep apnea.

Authors:  Carol E Smith; Emily Dauz; Faye Clements; Marilyn Werkowitch; Robert Whitman
Journal:  Patient Educ Couns       Date:  2008-09-30

8.  A pilot study of sleep, cognition, and respiration under 4 weeks of intermittent nocturnal hypoxia in adult humans.

Authors:  Matthew D Weiss; Renaud Tamisier; Judith Boucher; Mekkin Lynch; Geoffrey Gilmartin; J Woodrow Weiss; Robert Joseph Thomas
Journal:  Sleep Med       Date:  2009-03-17       Impact factor: 3.492

9.  Evaluation of a single-channel nasal pressure device to assess obstructive sleep apnea risk in laboratory and home environments.

Authors:  Kate E Crowley; Shantha M W Rajaratnam; Steven A Shea; Lawrence J Epstein; Charles A Czeisler; Steven W Lockley
Journal:  J Clin Sleep Med       Date:  2013-02-01       Impact factor: 4.062

10.  Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study.

Authors:  Douglas N Greve; Stephen P Duntley; Linda Larson-Prior; Andrew D Krystal; Michele T Diaz; Sean P A Drummond; Stephen G Thein; Clete A Kushida; Ronghua Yang; Robert J Thomas
Journal:  J Clin Sleep Med       Date:  2014-02-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.